Zhejiang Shapuaisi Pharmaceutical Co., Ltd. (603168.SH): Shanghai Jingxing reduced its holdings by a total of 1.6619 million shares, the holding period has expired.

26/02/2025

GMT Eight

Zhejiang Shapuaisi Pharmaceutical (603168.SH) announced that the reduction time interval of Shanghai Jingxing's plan to reduce its shareholding in November 22, 2024 has expired. From November 27, 2024 to February 26, 2025, Shanghai Jingxing reduced its shareholding of Zhejiang Shapuaisi Pharmaceutical by 1,661,900 shares through centralized bidding trading.

HK Stock Market Move | Food and beverage stocks are strong, NAYUKI (02150) surged over 30% in the closing period, HELENS (09869) rose over 9%.

Subsidiary of Zhejiang Medicine (stock code 600216.SH), Innovate Biopharmaceuticals, passed the on-site inspection by the US FDA.

Contact: contact@gmteight.com

Zhejiang Shapuaisi Pharmaceutical Co., Ltd. (603168.SH): Shanghai Jingxing reduced its holdings by a total of 1.6619 million shares, the holding period has expired.

RECOMMEND

ISP GLOBAL (08487) announces interim results with a shareholder's net loss of HK$7.912 million, a year-on-year increase of 58.3%.

LAOPU GOLD (06181) issued 597,000 bonus shares.

COOLPAD GROUP (02369) has fulfilled all conditions for resumption of trading and will resume trading on February 27th.